Recombinant CMV gB Vaccine in Postpartum Women

Clinical trial NCT00125502 · COMPLETED

Trial details

NCT number: NCT00125502
Sponsor: Robert Pass, MD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 1999-08-01
Primary completion: 2007-06-01
Enrollment: 464

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.